• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺腺癌相关恶性胸腔积液患者的外泌体微小RNA表达谱分析

Exosomal MicroRNA Expression Profiling in Patients with Lung Adenocarcinoma-associated Malignant Pleural Effusion.

作者信息

Tamiya Hiroyuki, Mitani Akihisa, Saito Akira, Ishimori Taro, Saito Minako, Isago Hideaki, Jo Taisuke, Yamauchi Yasuhiro, Tanaka Goh, Nagase Takahide

机构信息

The Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo, Japan.

The Department of Respiratory Medicine, The University of Tokyo Hospital, Tokyo, Japan

出版信息

Anticancer Res. 2018 Dec;38(12):6707-6714. doi: 10.21873/anticanres.13039.

DOI:10.21873/anticanres.13039
PMID:30504380
Abstract

BACKGROUND/AIM: Cytological analysis for diagnosing malignant pleural effusion associated with lung adenocarcinoma (Ad-MPE) shows limited sensitivity and novel diagnostic biomarkers are needed. The aim of this study was to evaluate the profile of four microRNAs (miRNAs) in exosomes in Ad-MPE and benign (non-neoplastic) pleural effusion (BPE).

MATERIALS AND METHODS

A total of 56 pleural effusion samples from patients with lung adenocarcinoma and benign diseases were collected. Exosomal miRNA expressions were evaluated using real-time quantitative reverse transcription polymerase chain reaction (RT-PCR).

RESULTS

The expression levels of miR-182 and miR-210 were significantly higher in the Ad-MPE than in the BPE samples. The receiver operating characteristics curve analyses of miR-182 and miR-210 for diagnosis of Ad-MPE yielded areas under the receiver operating characteristic curves of 0.87 and 0.81, respectively.

CONCLUSION

These miRNA signatures may have a diagnostic potential for differentiating Ad-MPE from BPE.

摘要

背景/目的:用于诊断与肺腺癌相关的恶性胸腔积液(Ad-MPE)的细胞学分析显示敏感性有限,因此需要新的诊断生物标志物。本研究的目的是评估Ad-MPE和良性(非肿瘤性)胸腔积液(BPE)中外泌体中四种微小RNA(miRNA)的特征。

材料与方法

共收集了56例来自肺腺癌患者和良性疾病患者的胸腔积液样本。使用实时定量逆转录聚合酶链反应(RT-PCR)评估外泌体miRNA的表达。

结果

Ad-MPE中miR-182和miR-210的表达水平显著高于BPE样本。miR-182和miR-210用于诊断Ad-MPE的受试者工作特征曲线分析得出的受试者工作特征曲线下面积分别为0.87和0.81。

结论

这些miRNA特征可能具有区分Ad-MPE和BPE的诊断潜力。

相似文献

1
Exosomal MicroRNA Expression Profiling in Patients with Lung Adenocarcinoma-associated Malignant Pleural Effusion.肺腺癌相关恶性胸腔积液患者的外泌体微小RNA表达谱分析
Anticancer Res. 2018 Dec;38(12):6707-6714. doi: 10.21873/anticanres.13039.
2
Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.细胞游离 miR-198 下调作为肺腺癌相关恶性胸腔积液的诊断生物标志物。
Int J Cancer. 2013 Aug 1;133(3):645-52. doi: 10.1002/ijc.28054. Epub 2013 Feb 25.
3
Exosomal miRNA profiling before and after surgery revealed potential diagnostic and prognostic markers for lung adenocarcinoma.手术前后外泌体 miRNA 谱分析揭示了肺腺癌潜在的诊断和预后标志物。
Acta Biochim Biophys Sin (Shanghai). 2020 Mar 18;52(3):281-293. doi: 10.1093/abbs/gmz164.
4
Diagnostic value of microRNAs derived from exosomes in bronchoalveolar lavage fluid of early-stage lung adenocarcinoma: A pilot study.来源于支气管肺泡灌洗液中囊泡的 microRNAs 在早期肺腺癌中的诊断价值:一项初步研究。
Thorac Cancer. 2018 Aug;9(8):911-915. doi: 10.1111/1759-7714.12756. Epub 2018 May 28.
5
Combination of DNA ploidy analysis and miR-21 or miR-24 in screening malignant pleural effusion.DNA倍体分析与miR-21或miR-24联合用于恶性胸腔积液的筛查
Interact Cardiovasc Thorac Surg. 2018 Mar 1;26(3):376-381. doi: 10.1093/icvts/ivx327.
6
Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion.评估血清和胸腔积液中的一组 microRNA 用于良恶性胸腔积液的鉴别诊断。
Cancer Biomark. 2022;33(1):71-82. doi: 10.3233/CBM-210090.
7
Identification of differentially expressed miRNAs in differentiating benign from malignant pleural effusion.鉴别良、恶性胸腔积液中差异表达的 microRNAs。
Hereditas. 2020 Feb 26;157(1):6. doi: 10.1186/s41065-020-00119-z.
8
Diagnostic Value of Circulating Extracellular miR-134, miR-185, and miR-22 Levels in Lung Adenocarcinoma-Associated Malignant Pleural Effusion.循环细胞外 miR-134、miR-185 和 miR-22 水平在肺腺癌相关恶性胸腔积液中的诊断价值。
Cancer Res Treat. 2014 Apr;46(2):178-85. doi: 10.4143/crt.2014.46.2.178. Epub 2014 Apr 22.
9
Exosomal RNA-profiling of pleural effusions identifies adenocarcinoma patients through elevated miR-200 and LCN2 expression.胸腔积液外泌体 RNA 分析通过提高 miR-200 和 LCN2 的表达来鉴定腺癌患者。
Lung Cancer. 2018 Oct;124:45-52. doi: 10.1016/j.lungcan.2018.07.018. Epub 2018 Jul 27.
10
Tumor-derived circulating exosomal miR-342-5p and miR-574-5p as promising diagnostic biomarkers for early-stage Lung Adenocarcinoma.肿瘤来源的循环外泌体 miR-342-5p 和 miR-574-5p 作为早期肺腺癌有前途的诊断生物标志物。
Int J Med Sci. 2020 Jun 6;17(10):1428-1438. doi: 10.7150/ijms.43500. eCollection 2020.

引用本文的文献

1
Exosomal miR-182-5p is a potential diagnostic marker for malignant pleural effusion.外泌体miR-182-5p是恶性胸腔积液的一种潜在诊断标志物。
Transl Lung Cancer Res. 2025 Apr 30;14(4):1138-1148. doi: 10.21037/tlcr-2024-1205. Epub 2025 Apr 16.
2
Unraveling the Connection: Extracellular Vesicles and Non-Small Cell Lung Cancer.解析关联:细胞外囊泡与非小细胞肺癌。
Int J Nanomedicine. 2024 Aug 9;19:8139-8157. doi: 10.2147/IJN.S477851. eCollection 2024.
3
From biogenesis to aptasensors: advancements in analysis for tumor-derived extracellular vesicles research.
从生物发生学到适体传感器:肿瘤衍生细胞外囊泡研究分析的进展。
Theranostics. 2024 Jul 2;14(10):4161-4183. doi: 10.7150/thno.95885. eCollection 2024.
4
Diagnostic value of exosomal noncoding RNA in lung cancer: a meta-analysis.外泌体非编码RNA在肺癌中的诊断价值:一项荟萃分析。
Front Oncol. 2024 Apr 17;14:1357248. doi: 10.3389/fonc.2024.1357248. eCollection 2024.
5
Extracellular Vesicles and Exosomes: Novel Insights and Perspectives on Lung Cancer from Early Detection to Targeted Treatment.细胞外囊泡与外泌体:从肺癌早期检测到靶向治疗的新见解与展望
Biomedicines. 2024 Jan 7;12(1):123. doi: 10.3390/biomedicines12010123.
6
Exosomal Non-coding RNAs: A New Approach to Melanoma Diagnosis and Therapeutic Strategy.外泌体非编码 RNA:一种用于黑色素瘤诊断和治疗策略的新方法。
Curr Med Chem. 2024;31(37):6084-6109. doi: 10.2174/0109298673267553231017053329.
7
The Emerging Role of Exosomal miRNAs as Biomarkers for Early Cancer Detection: A Comprehensive Literature Review.外泌体 miRNA 作为癌症早期检测生物标志物的新兴作用:全面文献综述。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231205999. doi: 10.1177/15330338231205999.
8
Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts.外泌体纳米囊泡作为肺癌微环境中潜在的生物标志物和免疫检查点信号调节剂:最新进展和新兴概念。
J Exp Clin Cancer Res. 2023 Aug 29;42(1):221. doi: 10.1186/s13046-023-02753-7.
9
Application of Non-Blood-Derived Fluid Biopsy in Monitoring Minimal Residual Diseases of Lung Cancer.非血液来源的液体活检在监测肺癌微小残留病中的应用。
Front Surg. 2022 May 16;9:865040. doi: 10.3389/fsurg.2022.865040. eCollection 2022.
10
Tumor-derived exosomes: immune properties and clinical application in lung cancer.肿瘤衍生外泌体:肺癌中的免疫特性及临床应用
Cancer Drug Resist. 2022 Feb 8;5(1):102-113. doi: 10.20517/cdr.2021.99. eCollection 2022.